
|Videos|March 19, 2021
Dr. Richard Lee on why it’s “a wonderful time” for BPH treatment
Author(s)Urology Times staff
“The take-home message is that for the appropriate patient, each of [these] technologies works well,” says Richard K. Lee, MD, MBA.
Advertisement
In this interview, Richard K. Lee, MD, MBA, discusses the recent paper European Urology Focus paper, New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review, for which he served senior author. Lee is an Associate Professor of Urology and Healthcare Policy & Research at Weill Cornell Medicine Department of Urology in New York City.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Practical guide to female pelvic organ–sparing radical cystectomy
2
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
3
Pearls & Perspectives: Navigating Evidence Gaps and Innovation in OAB Care, With Ariana Smith, MD
4
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
5






